Mushrooms, their bioactive compounds and medicinal uses: A review

Medicinal Plants

Volumn 5, Issue 1, 2013, Pages 1-20

  Thakur, M P ^a   Singh, Harvinder K ^a  

^a INDIRA GANDHI AGRICULTURAL UNIVERSITY   (India)

Author keywords

Bioactive compounds; Cordyceps sinensis; Ganoderma lucidum; Medicinal importance; Mushrooms; Polysaccharide protein complexes; Polysaccharides

Indexed keywords

ALPHA TOCOPHEROL; CORDYCEPIN; CYANOCOBALAMIN; FUNGAL EXTRACT; GLYCOPROTEIN; KRESTIN; LECTIN; MEVINOLIN; PLANT MEDICINAL PRODUCT; PLEUROMUTILIN; POLYCHLORINATED TERPHENYL; POLYSACCHARIDE; RIBOFLAVIN; SPERMIDINE; TERPENOID; THIAMINE; THIONEINE; VITAMIN K GROUP;

ANTIDIABETIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; GANODERMA LUCIDUM; GRIFOLA FRONDOSA; HUMAN; LENTINULA EDODES; MEDICINAL MUSHROOM; NONHUMAN; OPHIOCORDYCEPS; PHELLINUS; PLEUROTUS OSTREATUS; PRIORITY JOURNAL; REVIEW; SCHIZOPHYLLUM COMMUNE; TRAMETES VERSICOLOR;

EID: 84877707483     PISSN: 09754261     EISSN: 09756892     Source Type: Journal    
DOI: 10.5958/j.0975-6892.5.1.004     Document Type: Review

References (78)

1. Adhikari M. K (1981). Chyau: Ayurvediya vishleshan ek vivechana (Mushrooms: An Ayurvedic concepts). J. Nep. Pharm. Asso., 9: 17-21.
2. Akamatsu S., Watanabe A and Tamesada M (2004). Hepatoprotective effect of extracts from Lentinus edodes mycelia on dimethylnitrosamine-induced liver injury. Biol. Pharm. Bull., 27: 1957-60.
3. Bae E-A, Kim DH and Han MJ (1997). Effect of Lentinus edodes on the growth of intestinal lactic acid bacteria. Archives Pharmaceutical Research, 20: 443-447.
4. Chang S. T (1999). Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution. Int. J. Med. Mushrooms, 1: 1-8.
5. Chang S. T and Wassar SP (2012). The role of culinarymedicinal mushroom on human welfare with a pyramid model for human health. Int. J. Med. Mushrooms, 1: 95-134.
6. Chang S. T and Buswell JA (1996). Mushroom nutriceuticals. World Journal of Microbiology and Biotechnology, 12: 473-476.
7. Clark D. and Adams M (2009). "A commercial nutraceutical mix Metabolic Cell-Support (MC-S) inhibits proliferation of cancer cell lines in vitro", Austr. J. Med. Herbal., 21: 39-43.
8. De Lima PL, Delmanto RD and Sugui MM (2001). Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res., 496: 23-32.
9. De Vere White RW, Hackman RM, Soares SE, Beckett LA and Sun B. (2002). Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology, 60: 640-4.
10. Dong Y., Yang MM, Kwan CY (1997). "In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs", Life Sci., 60(8): 135-140.
11. Fisher M. Y (2002). "Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer research 22 (3): 1737-1754.
12. Gao Y., Lan J, Dai X, Ye J and Zhou SH (2004). A phase I/ II study of Ling Zhi mushroom Ganoderma lucidum. (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int. J. Med. Mushrooms, 6(1): 33-39.
13. Gao Y., Zhou S, Chen G, Dai X, Ye J and Gao H (2002). A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int. J. Med. Mushrooms, 4: 321-327.
14. Han C. H, Liu QH, Ng TB and Wang HX (2005). A novel homodimeric lactosebnding lectin from the edible split gill medicinal mushroom Schizophyllum commune. Biochemical and Biophysical Research Communication, 336: 252-257.
15. Hibasami H., Moteki H, and Ishikawa K (2003). Protodioscin isolated from fenugreek (Trigonella foenum graecum L.) induces cell death and morphological change indicative of apoptosis in leukemic cell line H-60, but not in gastric cancer cell line KATO III. Int. J. Mol. Med., 11: 23-6.
16. Hirata A., Ito W, Tabata K, Kojima T, Itoyama S and Suagawara I (1994). Anticoagulant activity of sulfated Schizophyllan. Bioscience, Biotechnology and Biochemistry, 58: 406-407.
17. Hobbs C. (1995). Medicinal Mushrooms: An exploration of Traditional, Healing and Culture. Santa Cruz, CA., Botanica Press.
18. Hsieh T. C and Wu JM (2001). "Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells", Int. J. Oncol., 18(1): 81-88.
19. Israilides C., Kletsas D and Arapoglou D (2008). In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine. 15: 512-519.
20. Ito W., Sugawara I, Kimura S, Tabata K, Hirata A, Kojima T and Shimada K (1990). Immunopharmacological study of sulfated Schizophyllan (SPG) I. Its action as a nitrogen and anti-HIV agent. International Journal of Immunopharmacology, 12: 225-233.
21. Jiménez-Medina E, Berruguilla E and Romero I (2008). "The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis", BMC Cancer, 8: 78, doi:10.1186/1471-2407-8-78, PMC 2291471, PMID 18366723.
22. Jong S. C and Birmingham JM (1992). Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol. 37: 101-134.
23. Kabir Y. and Kimura S (1989). Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats. Journal of Nutritional Science and Vitaminology, 35: 91-94.
24. Kakuma S. (1991). Effect of schizophyllan, a polysaccharide, on interferon gamma antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B. International Journal Immunopharmacology, 13: 969-975.
25. Kartikeyan S., Bharmal RN, Tiwari RP and Bisen PS (2007). HIV and AIDS: Basic Elements and Priorities, Springer Verlag: Dordrecht, The Netherlands.
26. Kidd P. M (2000). The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review, 5(1): 4-27.
27. Kimura Y. (1994). Clinical evaluation of sizofiran as assistant immunotherapy in treatment of head and neck cancer. Acta Otolargynzology, 511: 192-195.
28. Liu G. T (1999). Recent advances in research of pharmacology and clinical applications of Ganoderma P. Karst. species phyllophoromycetideae) in China. Int. J. Med. Mushrooms, 1(1), 63-68.
29. Lucas E. H, Montesono R, Pepper MS, Hafner M, Sablon E (1957). Tumor inhibitors in Boletus edulis and other holobasidiomycetes. Antibiot. Chemother., 7: 1-4.
30. Mains E. B (1940). Cordeceps species from Michigan (J). Papers Michigan Academy of Sciences, 25: 79-84.
31. Massce G. (1895). A revision of the genus Cordyceps (J). No. Bot., 9: 1-44.
32. Miyazaki K., Mizutani H, Katauchi H, Fukumaka K, Fujisaki S and Okamura H (1995). Activated (HLA-DR+) Tlymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiram on cellmediated immunity and survival. Gynaecologic Oncology, 56: 412-420.
33. Mizuno T. (1995). Bioactive biomolecules and mushrooms: food function and medicinal effects of mushroom fungi. Food Rev. Int., 11: 7-21.
34. Mizuno T. (1999). The extraction and development of antitumoractive polysaccharides from medicinal mushrooms in Japan (review) Int. J. Med. Mushr., 1: 9-30.
35. Mizuno T. (1995). Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev. Int., 11(1): 151-166.
36. Moncalvo J. M and Ryvarden L (1997). A Nomenclatural study of the Ganodermataceae Donk, Synopsis Fungorum 11, Fungiflora: Oslo, Norway, p. 114.
37. Muenzberg J., Rau U and Wagner F (1995). Investigations on the regioselective hydrolysis of a branched t-1,2-glucan. Carbohydrate Polymers, 27: 271-276.
38. Nakano T. and Oka K (1996). Intratumoral administration of sizofiran activates Langerhans cells and T-cell infiltration in cervical cancer. Clinical Immunology and Immunopathology, 79: 79-86.
39. Ng M. L and Yap AT (2002). Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J. Altern. Complement Med., 8: 581-589.
40. Ngai P. H and Ng TB (2003). Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells. Life Sci., 73: 3363-3374.
41. Oba K., Kobayashi M, Matsui T, Kodera Y and Sakamoto J (2009). Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res., 29: 2739-2745.
42. Oba K., Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. (2007). "Eff icacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer", Cancer Immunol. Immunother., 56(6): 905-911.
43. Okamoto T., Kodoi R and Nonaka Y (2004). Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors.21:407-409.
44. Okamura K., Kinukawa T, Tsumura Y, Otani T, Itoh T, Kobayashi H, Matsuura O, Kobayashi M, Fukutsu T and Ohshima S (1989). Adjuvant immunochemotherapy: two randomized controlled studies of patients with cervical cancer. Biomedical Pharmacotherapy, 43: 17.
45. Ooi V. EC and Liu F (1991). A review of pharmacological activities of mushroom polysaccharides. International Journal of Medicinal Mushrooms, 195-206.
46. Oso B. A (1981). Fungi and Mankind. Inaugural Lecture. University of Ibadan (Nigeria).
47. Rau Uand Brandt C (1994). Oxygen controlled batch cultivations of Schizophyllum commune for enhanced production of branched B-1,3-glucans. Bioprocess Engineering, 16: 161-165.
48. Rau U., Gura E, Olszewski E and Wagner F (1992). Enhanced glucan formation of filamentous fungi by effective mixing, oxygen limitation and fed-batch processing. Journal of Industrial Microbiology, 9: G19-26.
49. Reshetnikov S. V, Wasser SP and Tan KK (2001). Higher Basidiomycota as source of antitumor and immunostimulating polysaccharides. Int. J. Med. Mushrooms, 3: 361-394.
50. Saccardo P. A (1883). Cordyceps (J). Syll. Fungi, 2: 566-578.
51. Shiao M. S, Lee KR, Lin LJ and Wang CT (1994). Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum, in: Food Phytochemicals for Cancer Prevention. II: Teas, Spices and Herbs, (Ho, C.T., Osawa, T., Huang, M.T. and Rosen, R.T. Eds.), American Chemical Society: Washington, DC, p. 342-354.
52. Shimizu K., Watanabe S and Watanabe S (2009). Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology, 56: 240-4.
53. Shouji N., Takada K, Fukushima K and Hirasawa M (2000). Anticaries effect of a component from shiitake (an edible mushroom). Caries Res., 34: 94-8.
54. Shouji N. K, Takada K, Fukushima M Hirasawa and Tomotake N (1999). Three kinds of antibacterial substances from Lentinus edodes. International Journal of Antimicrobial Agents, 11: 151-157.
55. Singh R. P (2008). Caterpillar fungus (Cordyceps sinensis)-A review (J). Journal of Eco-friendly Agriculture, 3(1): 1-15.
56. Smith J., Rowan N and Sullivan R (2002). Medicinal Mushrooms:Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment; Special Report Commissioned by Cancer Research U. K, The University of Strathclyde in Glasgow, p. 256.
57. Sugimachi K., Maehara Y, Ogawa M, Kakegawa T and Tomita M (1997). "Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer", Cancer Chemother Pharmacol., 40(3):233-238.
58. Sugiyama K. and Yamakawa A (1996). Dietary eritadenineinduced alteration of molecular species composition of phospholipids in rats. Lipds, 31: 399-404.
59. Ulrike Lindequist, Timo H J Niedermeyer and Wolf-Dieter Jülich (2005). The Pharmacological Potential of Mushrooms Oxford University Press. Ecam., 2(3): 285-299
60. Van Griensven LJLD (2009). Culinary-medicinal mushrooms: must action be taken. Int. J. Med. Mushrooms, 11: 281-286.
61. Wasser S. P (2012). Modern view on current status, future trends, and unsolved problems in studies of medicinal mushrooms. Proc. 18th Congress of the International Society for Mushroom Scienec (eds Jinxia Zhang, Hexiyang Wang and Mingji Chen), China Agriculture Press, Beijing, pp. 401-415.
62. Wasser S. P (2002). Medicinal mushrooms as a source of antitumor and immunomodulatory polysaccharides. Appl. Microbiol. Biotechnol., 60: 258-274.
63. Wasser S. P (2002). Medicinal mushrooms as a source of antitumor and immunomodulatory polysaccharides. Appl. Microbiol. Biotechnol., 60: 258-274.
64. Wasser S. P and Weis AL (1999) Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspective (review). Int. J. Med. Mushr., 1: 31-62.
65. Wasser S. P and Weis AL (1999). Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int. J. Med. Mushrooms, 1: 31-62.
66. Wasser S. P (2002). Review of medicinal mushrooms advances: good news from good allies. Herbal Gram, 56: 28-33.
67. Wasser S. P and Weis AL (1997). Medicinal Mushrooms: Ganoderma lucidum, (Curtis: Fr.) P. Karst., (Nevo, E., Ed.), Peledfus Publ. House: Haifa, Israel, p. 39.
68. Wasser S. P and Weis AL (1999). Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol., 19: 65-96.
69. Wasser S. P (2010). Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int. J. Med. Mushrooms, 12(1): 1-16.
70. Wasson R. G (1968). Soma: Divine Mushroom of Immortality, Harcourt Brace Jovanovich Inc.; Los Angeles, USA, pp. 80-92.
71. Winkler D. (2008). Present and historic relevance of Yartsa Gunbu (Cordyceps sinensis). An ancient myco-medicinal in Tibet. Fungi, 1: 6-7.
72. Yamamoto Y. (1977). Immunopotentiating activity of the watersoluble lignin rich fractions prepared from LEM, the extract of the solid culture medium of Lentinus edodes mycelia. Bioscience, Biotechnology and biochemistry, 61: 1909-1912.
73. Yamasaki A., Shoda M and Iijima H (2009). A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model", Anticancer Res., 29(3): 843-50.
74. Yang M. M, Chen Z and Kwok JS (1992), "The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV)". Am J. Chin. Med., 20(3-4): 221-232.
75. Yun T. K (1999). Asian studies on cancer chemoprevention. Ann. N.Y. Acad. Sci., 889: 157-192.
76. Zaidman B., Yassin M, Mahajana J and Wasser SP (2005) Medicinal mushrooms modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol., 67: 453-468.
77. Zhang M., Cui SW, Cheung PCK and Wang Q (2007). Wang Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends in Food Science & Technology, 18: 4-19.
78. Zhou S. H and Gao Y (2002). The immunomodulating effects of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, reishi mushroom) (Aphyllophoromycetideae). Int. J. Med. Mushrooms, 4(1): 1-11.